Hyderabad-based healthcare startup Docturnal, focused on non-invasive tuberculosis screening solutions, has raised an undisclosed amount of funds from Mumbai Angels Network. The startup has secured funds from 11 investors through the Mumbai Angels Network.
Akshay Mittal, Founder of basmati rice maker Sagar Basmati Rice, angel investor Abhijeet Birewar, and Shantanu Agarwal, executive director at automotive furnishing fabric manufacturer BMD Pvt Ltd, were amongst the investors that participated in the funding round.
The funds raised will be used to deploy the product for clinical trials across several hospitals in the country, along with strengthening team and technology.
Docturnal was founded by Rahul Pathri, Balakrishna Bagadi, Arpita Singh and Vaishnavi Reddy in 2016. The startup provides non-invasive screening and diagnostics of diseases through technology. It offers flagship product TimBre, to help with tuberculosis screening, using real-time machine learning.
Mumbai Angels Network chief executive Nandini Mansinghka said that the network will look to invest more in the medtech and healthtech startups to support innovation in the domain.
“We see increased interest from the next level investors, both VC Funds and the strategic players in companies innovating in the medical and healthcare space using technology,” she added.
Mumbai Angels Network has more than 300 investors with investments in over 100 portfolio startups. Some of its prominent investments include agritech startup eFarm, global mobile advertising startup InMobi, online fashion retailer Myntra, healthcare technology company AllizHealth, and parenting platform BabyChakra, among many others.
Other players in the healthtech space competing with Docturnal include Medall Healthcare, MyHealthcare, Doxper, Netmeds, Cyclops Medtech, 3Hcare, NirogStreet, among many others.